Survivorship of Anatomic Total Shoulder Arthroplasty

J Am Acad Orthop Surg. 2022 May 15;30(10):457-465. doi: 10.5435/JAAOS-D-21-00302. Epub 2022 Mar 7.

Abstract

Anatomic total shoulder arthroplasty provides pain relief and improved quality of life for patients suffering from glenohumeral arthritis. The 10-year survival rate for these implants has been most recently reported at 96%. As the number of shoulder arthroplasties per year increases, it is important to evaluate factors associated with failure. Patient-specific variables such as age, sex, medical comorbidities, a history of previous shoulder surgery, and rotator cuff integrity can influence implant survival. Both surgeon and hospital volume have been shown to affect perioperative outcomes. Implant design and glenoid pathoanatomy are important structural considerations because both have a causal relationship with survivorship. Modifiable factors, such as smoking, body mass index, and alcohol or opioid consumption, should be addressed preoperatively when possible. Modifiable factors that pertain to surgery are equally as important; it is the responsibility of the surgeon to be aware of the reported outcomes for varying implants and technique-related pearls and pitfalls. For those perioperative factors that are nonmodifiable, it is prudent to counsel patients accordingly because these individuals may be more likely to require an eventual revision procedure.

MeSH terms

  • Arthroplasty, Replacement, Shoulder* / methods
  • Humans
  • Osteoarthritis* / surgery
  • Quality of Life
  • Range of Motion, Articular
  • Reoperation
  • Retrospective Studies
  • Shoulder Joint* / surgery
  • Survivorship
  • Treatment Outcome